| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |